The underlying pathology of rapid cognitive decline in AD has not been clarified but was associated with the presence of amyloid angiopathy [6], distinct protein or aggregate structures of Amyloid-beta [7, 8], or factors that modulate Tau pathology [9]. Here, MAPT is linked to Alzheimer disease.